oxophenylarsine has been researched along with Neoplasms in 1 studies
oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Excerpt | Relevance | Reference |
---|---|---|
"Phenylarsine oxide (PAO) has anticancer potential but it is considered as a toxic agent." | 1.56 | Melatonin triggers the anticancer potential of phenylarsine oxide via induction of apoptosis through ROS generation and JNK activation. ( Cui, ZG; Feng, QW; Inadera, H; Li, JL; Li, ML; Li, YL; Muhammad, JS; Sun, L; Zakki, SA, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Zakki, SA | 1 |
Muhammad, JS | 1 |
Li, JL | 1 |
Sun, L | 1 |
Li, ML | 1 |
Feng, QW | 1 |
Li, YL | 1 |
Cui, ZG | 1 |
Inadera, H | 1 |
1 other study available for oxophenylarsine and Neoplasms
Article | Year |
---|---|
Melatonin triggers the anticancer potential of phenylarsine oxide via induction of apoptosis through ROS generation and JNK activation.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Arsenicals; Cell Line, Tumor; Enzyme Activation; Enz | 2020 |